The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
Open accessAbstract
BACKGROUND.: Despite natural killer (NK) cells being originally identified and named because of their ability to kill tumor cells in vitro, only limited information is available on NK cells infiltrating malignant tumors, especially in humans. METHODS.: NK cells infiltrating human nonsmall cell lung cancers (NSCLC) were analyzed with the aim of identifying their potential protective role in an antitumor immune response. Both relevant molecule expression and functions of NK cells infiltrating NSCLC were analyzed in comparison with autologous NK cells isolated from either peritumoral normal lung tissues or peripheral blood. RESULTS.: The CD56 bright CD16− NK cell subset was consistently observed as being highly enriched in tumor infiltrate and displayed activation markers, including NKp44, CD69, and HLA‐DR. Remarkably, the cytolytic potential of NK cells isolated from cancer tissues was lower than that of NK cells from peripheral blood or normal lung tissue, whereas no difference was observed regarding their capability of producing cytokines. With regard to their localization within tumor, NK cells were found in tumor stroma, whereas they were not in direct contact with cancer cells. CONCLUSIONS.: For the first time NK cells infiltrating NSCLC have been characterized and it is shown that they are mainly capable of producing relevant cytokines rather than exerting direct cancer cell killing. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Biology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Self-citationThe effects of extracellular pH on immune function
Lardner, A. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.522 · Cited by 864
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
Natural-killer cells and dendritic cells: “l'union fait la force”
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005) · Blood · doi:10.1182/blood-2005-03-1154 · Cited by 634
Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1455 · Cited by 589
Self-citationPrognostic value of intratumoral natural killer cells in gastric carcinoma
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<577::aid-cncr13>3.0.co;2-v · Cited by 586
Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., Wu, L., & Butcher, E. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6477 · Cited by 517
Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H.-G., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051143 · Cited by 515
Romagnani, C., Juelke, K., Falco, M., Morandi, B., D’Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4947 · Cited by 494
Self-citationCD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells
Jacobs, R., Hintzen, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K.-W., & Schmidt, R. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3121::aid-immu3121>3.0.co;2-4 · Cited by 475
Villegas, F. R., Coca, S., Villarrubia, V. G., Jiménez, R., Chillón, M. J., Jareño, J., Zuil, M., & Callol, L. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00292-6 · Cited by 467
Yokoyama, W. M., & Seaman, W. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003145 · Cited by 461
Mocikat, R., Braumüller, H., Gumy, A., Egeter, O., Ziegler, H., Reusch, U., Bubeck, A., Louis, J., Mailhammer, R., Riethmüller, G., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00264-4 · Cited by 433
Wood, A. J. J., & Ihde, D. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272006 · Cited by 428
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
Rubio, V., Stuge, T. B., Singh, N., Betts, M. R., Weber, J. S., Roederer, M., & Lee, P. P. (2003) · Nature Medicine · doi:10.1038/nm942 · Cited by 400
Chan, A., Hong, D.-L., Atzberger, A., Kollnberger, S., Filer, A. D., Buckley, C. D., McMichael, A., Enver, T., & Bowness, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.89 · Cited by 366
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
Effector and regulatory events during natural killer–dendritic cell interactions
Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M. C., & Moretta, A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00450.x · Cited by 304
Self-citationIL-18–induced CD83+CCR7+NK helper cells
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., & Kalinski, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050128 · Cited by 286
Wolint, P., Betts, M. R., Koup, R. A., & Oxenius, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031799 · Cited by 265
Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., Dosaka‐Akita, H., & Nishimura, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01392.x · Cited by 252
Human natural killer cells: their origin, receptors and function
Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R., & Moretta, A. (2002) · European Journal of Immunology · Cited by 240
Self-citationNK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
Albertsson, P. A., Basse, P. H., Hokland, M., Goldfarb, R. H., Nagelkerke, J. F., Nannmark, U., & Kuppen, P. J. K. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.007 · Cited by 226
The role of tumor stroma in the interaction between tumor and immune system
Blankenstein, T. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.008 · Cited by 176
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
Takanami, I., Takeuchi, K., & Giga, M. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.113026 · Cited by 174
Schleypen, J. S., Baur, N., Kammerer, R., Nelson, P. J., Rohrmann, K., Gröne, E., Hohenfellner, M., Haferkamp, A., Pohla, H., Schendel, D. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0857 · Cited by 156
López‐Botet, M., Pérez‐Villar, J. J., Carretero, M., Rodríguez, A., Melero, I., Bellón, T., Llano, M., & Navarro, F. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00949.x · Cited by 144
NK cells: elusive players in autoimmunity
Johansson, S., Berg, L., Hall, H., & Höglund, P. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.008 · Cited by 121
Schleypen, J. S., von Geldern, M., Weiss, E., Kotzias, N., Rohrmann, K., Schendel, D. J., Falk, C. S., & Pohla, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11321 · Cited by 118
The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions
Loza, M. J., & PERUSSIA, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.88 · Cited by 114
The regulatory effect of natural killer cells: do "NK-reg cells" exist?
Zhang, C., Zhang, J., & Tian, Z. (2006) · PubMed · Cited by 98
Kuppen, P. J. K., van der Eb, M. M., Jonges, L. E., Hagenaars, M., Hokland, M., Nannmark, U., Goldfarb, R. H., Basse, P. H., Fleuren, G. J., Hoeben, R. C., et al. (2000) · Histochemistry and Cell Biology · doi:10.1007/s004180000224 · Cited by 65
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita∥, H., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4472 · Cited by 62
NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest
Trivedi, P. P., Roberts, P. C., Wolf, N. A., & Swanborg, R. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4590 · Cited by 57
Natural killer and dendritic cell liaison: Recent insights and open questions
Ferlazzo, G. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.04.015 · Cited by 39
Self-citationMelanoma immunotherapy: a battle against radicals?
Hellstrand, K. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00070-x · Cited by 16
Cited by
The lung microenvironment: an important regulator of tumour growth and metastasis
Altorki, N. K., Markowitz, G. J., Gao, D., Port, J. L., Saxena, A., Stiles, B., McGraw, T., & Mittal, V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0081-9 · Cited by 1,150
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45816 · Cited by 681
Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643
Metadata
- Authors
- Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-02
- Volume
- 112
- Issue
- 4
- Pages
- 863-875
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2075521813
- Cited by
- 379
- References
- 47
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.